GSK Reviews U.S. Media Duties on $1.4 Billion Account

NEW YORK (AdAge.com) — Drug giant GlaxoSmithKline is prepping a review of U.S. media duties on its massive $1.4 billion account.

No Responses to “GSK Reviews U.S. Media Duties on $1.4 Billion Account”

Post a Comment